Mylan Pharmaceuticals Inc.

Morgantown, WV, United States

Mylan Pharmaceuticals Inc.

Morgantown, WV, United States

Time filter

Source Type

News Article | November 28, 2016
Site: www.PR.com

Global Topical Drug Delivery Market, By Product Type (Topical Drug Delivery Formulations (Solid, Liquid, Semi Solid), Transdermal Drug Delivery Devices (Transdermal Patches, Transdermal Gels)), By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024 Dallas, TX, November 28, 2016 --( The global topical drug delivery market is segmented on the basis of product type, distribution channel, end user and geography. Request for sample pages: http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/ On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations. Topical drug delivery formulations are further segmented into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositors. The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels. Based on end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others. On the basis of distribution channel the market is segmented into Direct Tenders and Retail. The major geographies covered in the reports scope are North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market is further segmented into the countries like U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa. Read more: http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/ The major players operating in this market are MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Galderma S.A., Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Valeant Pharmaceuticals International, Inc., Skinvisible Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co., Inc., Pocono Coated Products LLC, TheraSolve NV., Samyang Biopharmaceuticals Corporation, Lohmann Therapie-Systeme AG, Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc., Novosis AG, Antares Pharma, Inc., Endo Pharmaceuticals Inc., Transdermal Technologies, Inc., Sheffield Pharmaceuticals, Inc., Solvay, and 3M Drug Delivery Systems among other vernacular players. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, November 28, 2016 --( PR.com )-- The market for Topical Drug Delivery is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at 9.2% during the forecast years to 2024.The global topical drug delivery market is segmented on the basis of product type, distribution channel, end user and geography.Request for sample pages: http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations. Topical drug delivery formulations are further segmented into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositors. The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.Based on end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.On the basis of distribution channel the market is segmented into Direct Tenders and Retail.The major geographies covered in the reports scope are North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market is further segmented into the countries like U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.Read more: http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/The major players operating in this market are MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Galderma S.A., Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Valeant Pharmaceuticals International, Inc., Skinvisible Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co., Inc., Pocono Coated Products LLC, TheraSolve NV., Samyang Biopharmaceuticals Corporation, Lohmann Therapie-Systeme AG, Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc., Novosis AG, Antares Pharma, Inc., Endo Pharmaceuticals Inc., Transdermal Technologies, Inc., Sheffield Pharmaceuticals, Inc., Solvay, and 3M Drug Delivery Systems among other vernacular players.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research


Patent
Mylan Pharmaceuticals Inc. | Date: 2011-09-21

Extended release pharmaceutical formulations are disclosed wherein the formulations contain an extended release portion and an immediate release portion, the extended release portion comprising an active pharmaceutical ingredient and a wax. Methods of making such extended release pharmaceutical formulations are also disclosed.


Trademark
Mylan Pharmaceuticals Inc. | Date: 2016-04-11

Pharmaceutical preparations for the treatment of diabetes.


Silicone adhesive formulations are provided, in which fentanyl particles are suspended one or more a solvated silicone adhesives. The formulations can be used for manufacturing improved, matrix-type transdermal devices for administering fentanyl.


Trademark
Mylan Pharmaceuticals Inc. | Date: 2016-02-18

Transdermal contraceptives.


Trademark
Mylan Pharmaceuticals Inc. | Date: 2016-10-28

Hormone Replacement Patch to treat the symptoms caused by menopause.


Trademark
Mylan Pharmaceuticals Inc. | Date: 2016-05-13

Transdermal contraceptives.


Silicone adhesive formulations are provided, in which fentanyl particles are suspended one or more a solvated silicone adhesives. The formulations can be used for manufacturing improved, matrix-type transdermal devices for administering fentanyl.


Patent
Mylan Pharmaceuticals Inc. | Date: 2015-05-05

The present application provides pharmaceutical compositions comprising as the active medicinal ingredient nebivolol, a nebivolol analog or a pharmaceutically acceptable acid addition salt thereof and a wetting agent. The invention also relates to methods of preparing and using said compositions.


Patent
Mylan Pharmaceuticals Inc. | Date: 2013-02-27

The present invention relates to pharmaceutical compositions containing a bisphosphonic acid in combination with a non-activated metabolize of vitamin D for oral administration. The compositions of the invention either do not contain or contain only low concentrations of a glidant. Also provided are methods for preparing such compositions and methods of use thereof, for preventing or treating abnormal bone resorption in mammals.

Loading Mylan Pharmaceuticals Inc. collaborators
Loading Mylan Pharmaceuticals Inc. collaborators